Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients (Q43980471)

28 November 2017

title

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

7

1 reference

28 November 2017

Roberto Fogari

1

1 reference

28 November 2017

Amedeo Mugellini

2

1 reference

28 November 2017

Annalisa Zoppi

3

1 reference

28 November 2017

Luca Corradi

4

1 reference

28 November 2017

Paola Preti

5

1 reference

28 November 2017

Pierangelo Lazzari

6

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Journal of Clinical Hypertension

28 November 2017

published in

1 reference

28 November 2017

volume

15

1 reference

28 November 2017

issue

4 Pt 1

1 reference

28 November 2017

page(s)

316-320

1 reference

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Impaired fibrinolysis and insulin resistance in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Plasma insulin, plasminogen activator inhibitor, and ankle-brachial systolic blood pressure ratio in overweight hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Diabetic and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Effect of captopril, losartan, and bradykinin on early steps of insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Bradykinin stimulates tissue plasminogen activator release in human vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902340-8

7 January 2021

10.1016/S0895-7061(01)02340-8

Identifiers

DOI

1 reference

28 November 2017

1 reference